Peptides.media

US FDA

FDA safety-risk page flags missing or limited safety information for several peptides

FDA lists potential safety and quality concerns for multiple nominated bulk drug substances, including peptide-related impurities, immunogenicity concerns, and missing human exposure data.

Status
Risk Flagged
Event type
Safety Risk

Primary source

Open source page

References

  1. 1.

    FDA. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks 2026.

    Accessed 2026-06-08.

    FDA summarizes potential significant safety risks and missing safety information for several nominated peptide bulk substances.